WVXU: Patients continue to feel the pain of prescription drug shortages
The University of Cincinnati's Emma Palmer joined WVXU's Cincinnati Edition to discuss recent national shortages of a variety of prescription drugs and the effect it has had on patients.
Many factors, including current regulations, higher rates of diagnosis and manufacturing issues, have contributed to the shortages for drugs to treat conditions including cancer, attention deficit hyperactivity disorder and diabetes.
"Some of the challenges that community pharmacies are facing are with the supply chain in terms of the amount of medications that can be ordered without geting a red flag essentially," said Palmer, PharmD, associate professor at UC's James L. Winkle College of Pharmacy. "So there’s a lot of fear and structure that has been built in to try to ensure that pharmacies are ordering appropriate amounts of medication, but they can’t always anticipate supply/demand appropriately."
Palmer said pharmacists and other members of a patient's treatment team work together to find alternatives if a specific medication is unavailable. But with many different formulations and each patient responding to medications differently, it is not always easy to find a replacement.
"If drug companies struggle to create the products that are in demand, and patients have specific products that they resopnd to, they may be scrambling to try to find another release or another formulation that may not be as beneficial for them," she said.
Patients can also struggle finding a pharmacy that can fill their full prescription, especially when prescriptions for Schedule 2 medications have time limitations before they expire.
"It’s not like someone can easily go to multiple pharmacies and get 10 pills here, 10 pills here, so a lot of families, a lot of patients have had to do a lot of calling around trying to find pharmacies that have the products in stock and trying to coordinate getting the prescription and getting it to the pharmacy in a timely manner before someone else gets those pills," Palmer said.
Listen to the Cincinnati Edition segment.
Featured photo at top of a woman speaking with her pharmacist. Photo/Drazen Zigic/iStock.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.